Advertisement


Mohammad Abu Zaid, MD, on Testicular Cancer: Study Results on Metabolic Syndrome

2017 Cancer Survivorship Symposium

Advertisement

Mohammad Abu Zaid, MD, of Indiana University Simon Cancer Center, discusses findings from a multicenter study of North American testicular cancer survivors, their prevalence of hypertension, risk factors for metabolic syndrome, and the need for screening and treatment (Abstract 102).



Related Videos

Breast Cancer
Symptom Management

Electra D. Paskett, PhD, on Preventing Lymphedema: Results of a CALGB Study

Electra D. Paskett, PhD, of The Ohio State University Comprehensive Cancer Center, discusses an intervention that increased knowledge of lymphedema in breast cancer, and the personal story that drove her research (Abstract 104).

Survivorship

Ann H. Partridge, MD, MPH, on Adolescent and Young Adult Patients: Their Survivorship Challenges

Ann H. Partridge, MD, MPH, of the Dana-Farber Cancer Institute, summarizes a session she co-chaired on the unique issues affecting adolescent and young adult patients, including their psychosocial needs and concerns that clinicians may overlook.

Survivorship

Allison Harvey, MPH, CHES, on Teaching Providers About Survivorship

Allison Harvey, MPH, CHES, of George Washington University, evaluates preliminary outcomes among primary care and oncology providers who took part in the Cancer Survivorship E-Learning Series (Abstract 78).

Survivorship
Pain Management
Breast Cancer

Sophia Kustas Smith, PhD, MSW, on Depression and Fatigue: Self-Managed in 'Reimagine'

Sophia Kustas Smith, PhD, MSW, of Duke University, discusses study findings on an online, symptom self-management curriculum, known as www.reimagine.me, employed for breast cancer survivors with chronic pain (Abstract 182).

Survivorship

Emily S. Tonorezos, MD, on Childhood Cancer Survivors and Late-Occurring Effects

Emily S. Tonorezos, MD, of Memorial Sloan Kettering Cancer Center, discusses childhood cancer survivors and the protection from late-occurring anthracycline-related cardiotoxicity conferred by a RARG coding variant.

Advertisement

Advertisement




Advertisement